It was aimed to make a retrospective analysis of the vaccines administered in the vaccine unit of our hospital since the beginning of the COVID-19 pandemic. The study was carried out retrospectively from the vaccination records our hospital, 14 January 2021 to 01 July 2022. In the 18-month period, a total of 75079 (100%) vaccines were administered, 59386 (79%) were Biontech and 15693 (21%) were Sinovac vaccines. Only Sinovac was available until June, therefore, 66% of the Sinovac vaccines were administered in the first five months period. After the Biontech vaccine started to be applied in our hospital, the rates of Sinovac vaccination have declined drastically. When the epidemic and vaccination graphs were examined separately, inverse correlation was found between the peak points of the epidemic and vaccine graphics. Biontech was found to be the most preferred vaccine by individuals against COVID-19 in this study.
{"title":"Retrospective Analysis of COVID-19 Vaccination in a University Hospital and the Relationship with the Epidemic Rate","authors":"I. Alıravcı, Fatma Gümüşer, A. Şener","doi":"10.33533/jpm.v16i2.4818","DOIUrl":"https://doi.org/10.33533/jpm.v16i2.4818","url":null,"abstract":"It was aimed to make a retrospective analysis of the vaccines administered in the vaccine unit of our hospital since the beginning of the COVID-19 pandemic. The study was carried out retrospectively from the vaccination records our hospital, 14 January 2021 to 01 July 2022. In the 18-month period, a total of 75079 (100%) vaccines were administered, 59386 (79%) were Biontech and 15693 (21%) were Sinovac vaccines. Only Sinovac was available until June, therefore, 66% of the Sinovac vaccines were administered in the first five months period. After the Biontech vaccine started to be applied in our hospital, the rates of Sinovac vaccination have declined drastically. When the epidemic and vaccination graphs were examined separately, inverse correlation was found between the peak points of the epidemic and vaccine graphics. Biontech was found to be the most preferred vaccine by individuals against COVID-19 in this study.","PeriodicalId":33234,"journal":{"name":"Jurnal Profesi Medika","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44918399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niken Puspa Kuspriyanti, Dina Nabila Lestari, Sofie Kaniawati
Diabetes mellitus causes lipid profile abnormalities, resulting in dyslipidemia in diabetic patients leading to ischemic stroke. This research aims to contrast lipid profiles in ischemic stroke patients with type 2 diabetes mellitus (T2DM) and non-type 2 diabetes mellitus (non-T2DM) to prevent stroke recurrence, treat dyslipidemia in diabetes mellitus, and evaluate for treatment of T2DM and non-T2DM ischemic stroke patients. A cross-sectional design was conducted at RSUD Ciamis using secondary medical record data in 2020. The data was collected using a nonprobability sampling approach, with the sampling extent determined by inclusion and exclusion criteria. Univariate analysis was used to determine the quantity and calculation. Besides, an independent t-test and chi-square test was utilized to test two hypotheses in bivariate analysis. Multifaceted analysis in age, gender, hypertension, and coronary heart disease was incorporated to observe its influence on T2DM and non-T2DM ischemic stroke patients. By using four lipid profile indicators, the differences were only in the triglyceride. While the total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were insignificant. Meanwhile, hypertension and coronary heart disease (CHD) significantly affect the incidence of ischemic stroke.
{"title":"a Comparison of Lipid Profile in Ischemic Stroke Patiens with Diabetes Mellitus and Non-Diabetes Mellitus at Rumah Sakit Umum Daerah Ciamis 2020","authors":"Niken Puspa Kuspriyanti, Dina Nabila Lestari, Sofie Kaniawati","doi":"10.33533/jpm.v16i2.4809","DOIUrl":"https://doi.org/10.33533/jpm.v16i2.4809","url":null,"abstract":"Diabetes mellitus causes lipid profile abnormalities, resulting in dyslipidemia in diabetic patients leading to ischemic stroke. This research aims to contrast lipid profiles in ischemic stroke patients with type 2 diabetes mellitus (T2DM) and non-type 2 diabetes mellitus (non-T2DM) to prevent stroke recurrence, treat dyslipidemia in diabetes mellitus, and evaluate for treatment of T2DM and non-T2DM ischemic stroke patients. A cross-sectional design was conducted at RSUD Ciamis using secondary medical record data in 2020. The data was collected using a nonprobability sampling approach, with the sampling extent determined by inclusion and exclusion criteria. Univariate analysis was used to determine the quantity and calculation. Besides, an independent t-test and chi-square test was utilized to test two hypotheses in bivariate analysis. Multifaceted analysis in age, gender, hypertension, and coronary heart disease was incorporated to observe its influence on T2DM and non-T2DM ischemic stroke patients. By using four lipid profile indicators, the differences were only in the triglyceride. While the total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were insignificant. Meanwhile, hypertension and coronary heart disease (CHD) significantly affect the incidence of ischemic stroke.","PeriodicalId":33234,"journal":{"name":"Jurnal Profesi Medika","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46400514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-29DOI: 10.35990/mk.v5n3.p308-320
Frita Ferlita Shafri Djohan, Florence Meliawaty
Porphyromonas gingivalis merupakan bakteri patogen dalam penyakit periodontitis kronis. Kandungan senyawa organik daun sirih merah (Piper crocatum) memiliki efek antibakteri. Ekstrak Piper crocatum diharapkan dapat digunakan sebagai terapi penunjang penyakit periodontitis kronis. Penelitian ini bertujuan untuk mengetahui efek antibakteri ekstrak Piper crocatum melalui uji daya hambat terhadap Porphyromonas gingivalis. Prosedur kerja dengan membuat sampel ekstrak etanol 80% daun sirih merah dengan konsentrasi 2,5%; 5%; dan 10% dalam 10 mL DMSO 10%. Kultur biakan bakteri P. gingivalis ATCC 33277 di media Lempeng Agar Darah (LAD). Uji daya hambat dengan metode Kirby Bower pada konsentrasi ekstrak 2.5%, 5%, 10% pengulangan sebanyak tiga kali pada LAD berisi bakteri. Hasil uji daya hambat yaitu tidak didapat zona bening pada konsentrasi ekstrak 2.5%, 5%, 10%. Kontrol positif tidak ada dan kemungkinan bakteri terkontaminasi dapat menjadi penyebab zona bening tidak terbentuk. Ekstrak Piper crocatum pada konsentrasi 2,5%, 5%, dan 10% tidak memiliki efek terhadap bakteri P. gingivalis.
{"title":"UJI DAYA ANTIBAKTERI EKSTRAK DAUN SIRIH MERAH (Piper crocatum) TERHADAP BAKTERI Porphyromonas gingivalis SEBAGAI TERAPI PENUNJANG PERIODONTITIS KRONIS","authors":"Frita Ferlita Shafri Djohan, Florence Meliawaty","doi":"10.35990/mk.v5n3.p308-320","DOIUrl":"https://doi.org/10.35990/mk.v5n3.p308-320","url":null,"abstract":"Porphyromonas gingivalis merupakan bakteri patogen dalam penyakit periodontitis kronis. Kandungan senyawa organik daun sirih merah (Piper crocatum) memiliki efek antibakteri. Ekstrak Piper crocatum diharapkan dapat digunakan sebagai terapi penunjang penyakit periodontitis kronis. Penelitian ini bertujuan untuk mengetahui efek antibakteri ekstrak Piper crocatum melalui uji daya hambat terhadap Porphyromonas gingivalis. Prosedur kerja dengan membuat sampel ekstrak etanol 80% daun sirih merah dengan konsentrasi 2,5%; 5%; dan 10% dalam 10 mL DMSO 10%. Kultur biakan bakteri P. gingivalis ATCC 33277 di media Lempeng Agar Darah (LAD). Uji daya hambat dengan metode Kirby Bower pada konsentrasi ekstrak 2.5%, 5%, 10% pengulangan sebanyak tiga kali pada LAD berisi bakteri. Hasil uji daya hambat yaitu tidak didapat zona bening pada konsentrasi ekstrak 2.5%, 5%, 10%. Kontrol positif tidak ada dan kemungkinan bakteri terkontaminasi dapat menjadi penyebab zona bening tidak terbentuk. Ekstrak Piper crocatum pada konsentrasi 2,5%, 5%, dan 10% tidak memiliki efek terhadap bakteri P. gingivalis.","PeriodicalId":33234,"journal":{"name":"Jurnal Profesi Medika","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85023427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-29DOI: 10.35990/mk.v5n3.p265-274
Dinna Rakhmani, Aini Luthfiah Hayati, Tini Elyn Herlina
Hepatitis B adalah infeksi yang disebabkan oleh virus Hepatitis B dan menyerang jaringan hati. Virus Hepatitis B dapat menular melalui darah dan cairan tubuh penderita. Infeksi Hepatitis B dapat dicegah dengan melakukan vaksinasi. Kekebalan tubuh terhadap infeksi virus Hepatitis B ditandai dengan adanya kandungan Anti-HBs. Anti-HBs merupakan antibodi protektif terhadap infeksi virus Hepatitis B. Kadar protektif Anti-HBs terhadap infeksi virus Hepatitis B sebesar ≥10 mIU/mL. Penelitian ini bertujuan untuk mengetahui profil anti-HBs pada mahasiswa Teknologi Laboratorium Medis Poltekkes Kemenkes Banjarmasin. Metode penelitian menggunakan survei deskriptif dengan rancangan cross sectional. Teknik pengambilan sampel yang digunakan yaitu purposive sampling. Populasi penelitian ini adalah mahasiswa Teknologi Laboratorium Medis dengan jumlah sampel penelitian sebanyak 41 responden. Anti-HBs dalam darah dideteksi menggunakan rapid test HBsAb. Hasil penelitian menunjukkan pada 19 mahasiswa yang telah melakukan vaksinasi didapatkan hasil pemeriksaan Anti-HBs sebanyak 17 orang positif dan 2 orang negatif. Sedangkan pada 22 mahasiswa yang belum melakukan vaksinasi didapatkan hasil pemeriksaan anti-HBs negatif pada seluruh responden. Dapat disimpulkan bahwa antibodi anti-HBs pada mahasiswa muncul karena vaksinasi.
{"title":"PROFIL ANTI-HBS PADA MAHASISWA TEKNOLOGI \u0000LABORATORIUM MEDIS POLTEKKES KEMENKES BANJARMASIN","authors":"Dinna Rakhmani, Aini Luthfiah Hayati, Tini Elyn Herlina","doi":"10.35990/mk.v5n3.p265-274","DOIUrl":"https://doi.org/10.35990/mk.v5n3.p265-274","url":null,"abstract":"Hepatitis B adalah infeksi yang disebabkan oleh virus Hepatitis B dan menyerang jaringan hati. Virus Hepatitis B dapat menular melalui darah dan cairan tubuh penderita. Infeksi Hepatitis B dapat dicegah dengan melakukan vaksinasi. Kekebalan tubuh terhadap infeksi virus Hepatitis B ditandai dengan adanya kandungan Anti-HBs. Anti-HBs merupakan antibodi protektif terhadap infeksi virus Hepatitis B. Kadar protektif Anti-HBs terhadap infeksi virus Hepatitis B sebesar ≥10 mIU/mL. Penelitian ini bertujuan untuk mengetahui profil anti-HBs pada mahasiswa Teknologi Laboratorium Medis Poltekkes Kemenkes Banjarmasin. Metode penelitian menggunakan survei deskriptif dengan rancangan cross sectional. Teknik pengambilan sampel yang digunakan yaitu purposive sampling. Populasi penelitian ini adalah mahasiswa Teknologi Laboratorium Medis dengan jumlah sampel penelitian sebanyak 41 responden. Anti-HBs dalam darah dideteksi menggunakan rapid test HBsAb. Hasil penelitian menunjukkan pada 19 mahasiswa yang telah melakukan vaksinasi didapatkan hasil pemeriksaan Anti-HBs sebanyak 17 orang positif dan 2 orang negatif. Sedangkan pada 22 mahasiswa yang belum melakukan vaksinasi didapatkan hasil pemeriksaan anti-HBs negatif pada seluruh responden. Dapat disimpulkan bahwa antibodi anti-HBs pada mahasiswa muncul karena vaksinasi.","PeriodicalId":33234,"journal":{"name":"Jurnal Profesi Medika","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87064182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}